-
Domainex opens for business in Boston and San Diego
Jul 19, 2018, 05:23 AM by Michael CroftCAMBRIDGE, UK - Jul 19, 2018 - Domainex Ltd, Europes fastest growing drug discovery service company, is pleased to announce its expansion to the US with the appointment of a new business development team and the opening of East and West coast offices in Boston, MA and San Diego, CAFull story -
Aircuity Highlights Platform for Reducing Energy Use and Improving the Indoor Environment at the NACUBO 2018 Annual Meeting
Jul 18, 2018, 14:26 PM by Michael CroftNEWTON, MA, UNITED STATES - Jul 18, 2018 - Aircuity, (www.aircuity.com), creator of measurably better environments, will be highlighting the benefits of its platform for optimizing ventilation at universities during the National Association of College and University Business Officers NACUBO 2018 Annual MeetingFull story -
Tetraphase Selects SHYFT To Support Data And Analytics For Commercial Launch Readiness
Jul 18, 2018, 14:00 PM by Michael CroftFull storyBio-IT World Brief | SHYFT Analytics announced Tetraphase has selected its platform to support the anticipated commercial launch of eravacycline, its lead antibiotic candidate developed to address multidrug-resistant bacteria.
-
AWS Unveils New HPC Instances With Fast Cores
Jul 18, 2018, 09:39 AM by Michael CroftTOP500 | Amazon Web Services has announced a new set of instances designed for applications that can benefit from high core performance.Full story -
Creative Biolabs Established a Comprehensive Phage Display Systems for Lab Use
Jul 17, 2018, 23:49 PM by Michael CroftSHIRLEY, NY - Jul 18, 2018 - July 17, 2018, with decades of experience, Creative Biolabs has extensive expertise in various antibody production and engineering fieldsFull story -
IVD Raw Materials Are Launched by Creative Diagnostics for bio-researchers
Jul 17, 2018, 23:45 PM by Michael CroftSHIRLEY, NY, UNITED STATES - Jul 18, 2018 - As a global leader in the manufacture of raw materials, reagents and antibodies for biotechnology industry, Creative Diagnostics recently launches varieties of IVD raw materials to the global marketplace for life science applicationsFull story -
Verodin Closes $21M Series B Financing to Capture Global Demand for Cybersecurity Effectiveness
Jul 17, 2018, 18:49 PM by Michael CroftMCLEAN, VA - Jul 17, 2018 - Verodin, the leader in validating the effectiveness of cybersecurity controls, today announced $21M in Series B funding led by TenEleven Ventures and Bessemer Venture Partners (BVP)Full story -
Genstar Capital to Acquire CRF Health from Vitruvian Partners and Combine with Bracket
Jul 17, 2018, 15:30 PM by Michael Croft, PA - Jul 17, 2018 - London, United Kingdom and Wayne, Pennsylvania, USA - Genstar Capital, a leading investor in healthcare technology and services companies, is pleased to announce the acquisition of CRF Health, a global provider of eCOA and eConsent solutions for the life sciences industryFull story -
ZEISS expands X-ray imaging portfolio with ZEISS Xradia Context microCT
Jul 17, 2018, 10:19 AM by Michael CroftJENA, GERMANY - Jul 17, 2018 - Built on renowned ZEISS Xradia platform and field-convertible to ZEISS Xradia Versa X-ray microscopeJENA/GermanyZEISS introduces a new X-ray imaging instrument, ZEISS Xradia Context microCT, a large field-of-view, non-destructive 3D X-ray microcomputed tomography systemFull story -
Sekisui XenoTech Receives New US Patent for Kit and Method to Evaluate Xenobiotic Drug Metabolism in Hepatocytes
Jul 17, 2018, 08:49 AM by Michael CroftKANSAS CITY, KS, UNITED STATES - Jul 17, 2018 - Sekisui XenoTech has been awarded US patent # 10,001,471 "In vitro test system to evaluate xenobiotics as immune-modulators of drug transport and metabolism in human hepatocytesFull story -
Government Insurers Balk At Paying For CAR-T Cancer Drug
Jul 17, 2018, 08:44 AM by Michael CroftNPR | Treatment costs for the immunotherapy can run to more than $1 million. Some state Medicaid programs aren't paying for the treatment, and Medicare's complicated payment rates have hospitals worried.Full story -
Inflection Biosciences Announces Publication of Positive Data for Dual Mechanism Inhibitor Against Chronic Lymphocytic Leukaemia
Jul 17, 2018, 05:30 AM by Michael CroftDUBLIN, IRELAND - Jul 17, 2018 - Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, today announced the publication of preclinical data showing the companys dual mechanism PIM/PI3 kinase inhibitor IBL-202 has promise as a treatment for chronic lymphocytic leukaemia (CLL)Full story -
Another CRISPR Calamity? U.K. Team Reports CRISPR-Induced Gene Rearrangements
Jul 16, 2018, 12:38 PM by Michael CroftGEN | Scientists at the Wellcome Sanger Institute in the U.K. have reported another potential hurdle for the CRISPR community, publishing findings today that call the precision of CRISPR-Cas9 gene editing into question.Full story -
Rho Offers Tips for Cellular Therapy Studies
Jul 16, 2018, 12:32 PM by Michael CroftCHAPEL HILL, NC - Jul 17, 2018 - For Immediate Release Rho Offers Tips for Cellular Therapy StudiesCRO shares challenges for cellular therapy in clinical trials Chapel Hill, NC ̶ July 16, 2018 Rho, a contract research organization (CRO) focused on bringing new products to market through a full range of product development services, offers tips on overcoming the challenges associated with cellular therapy clinical trialsFull story -
Leading Alzheimer's Disease scientist joins NeuroCog Trials
Jul 16, 2018, 11:34 AM by Michael CroftDURHAM, NC, US - Jul 16, 2018 - Dr. Kathleen Anne Welsh-Bohmer, a specialist in Alzheimers Disease (AD) research, has joined the scientific leadership team at NeuroCog Trials (NCT) as the Vice President of Neurodegenerative DisordersFull story -
Leaders In Biobanking Congress: Unlocking The Potential
Jul 16, 2018, 11:25 AM by Michael CroftFull storyBio-IT World | This year, the 10th annual Leaders in Biobanking Congress will take place in Cleveland, Ohio from October 14-16. Biomedical and biopharmaceutical researchers, regulators, biorepository managers, and practitioners will converge to discuss the various aims for biospecimen collections, from basic research to clinical trials.
-
MR Solutions installs Hawaii’s first preclinical MRI imaging system
Jul 16, 2018, 08:18 AM by Michael CroftGUILDFORD, UNITED KINGDOM - Jul 16, 2018 - MR Solutions has installed Hawaiis first preclinical cryogen-free MRI imaging system to help researchers improve the rate of kidney disease detection through researchFull story -
Protein Dynamic Solutions named to “The most valuable venture-backed startups in all 50 states”
Jul 15, 2018, 18:20 PM by Michael CroftWAKEFIELD, MA - Jul 16, 2018 - Protein Dynamic Solutions LLC (PDS), developer of breakthrough technologies for structural characterization of therapeutic proteins, was recognized by Business Insiderfor provision of instruments and contract research services to the biopharmaceutical industryFull story -
Superbugs Win Another Round As Big Pharma Leaves Antibiotics
Jul 13, 2018, 10:26 AM by Michael CroftBloomberg | The fight against life-threatening infections suffered another blow when one of the world's biggest drugmakers waved the white flag. Novartis is the latest drug giant to end antibacterial and antiviral research, joining the like of AstraZeneca, Sanofi, and Allergan.Full story -
Wasdell Group launch serialisation service
Jul 12, 2018, 11:35 AM by Michael CroftSWINDON, UK - Jul 12, 2018 - The Wasdell Group (Wasdell), a leading outsourcing partner to companies within the pharmaceutical, medical device and clinical trials industries, has launched its serialisation service ahead of the EU FMD and US DSCSA implementation deadlinesFull story